1. Home
  2. INMD

as of 12-05-2025 3:46pm EST

$14.44
+$0.10
+0.69%
Stocks Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus Nasdaq

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.

Chart Type:
Time Range:
Founded: 2008 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 879.2M IPO Year: 2019
Target Price: $17.00 AVG Volume (30 days): 568.8K
Analyst Decision: Hold Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 2.21 EPS Growth: 20.42
52 Week Low/High: $13.14 - $19.78 Next Earning Date: 11-05-2025
Revenue: $364,494,000 Revenue Growth: -13.98%
Revenue Growth (this year): -4.27% Revenue Growth (next year): 3.76%

AI-Powered INMD Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 3 days ago

AI Recommendation

hold
Model Accuracy: 75.17%
75.17%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: